UNSPSC 51273827: Menthol/methyl salicylate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE650. This VA Drug Class (DE650) classifies this compound as belonging to the group ANALGESICS, TOPICAL.

UNSPSC 51273827 Menthol/methyl salicylate is a Commodity code whose recent state and local procurement activity does not align meaningfully with the code's nominal scope. The three most recent opportunities posted under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which are menthol or methyl salicylate preparations. The mismatch suggests either a cataloging error in the tagging system or that the code is being used as a catch-all for miscellaneous pharmaceutical and medical supply procurement rather than as a product-specific taxonomy entry.

The issuing bodies include a county health department (Seminole County, Florida), a state health and human services commission (Texas HHS), and a multistate cooperative purchasing alliance (Minnesota MMCAP, serving state and local government facilities across participating jurisdictions including Oregon). The geographic activity centers on Florida, Texas, and the Upper Midwest. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; Texas HHS's April 2026 RFI on direct-to-manufacturer prescription programs; and Minnesota MMCAP's RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response date. Without recent opportunities actually soliciting menthol or methyl salicylate products, the code shows little actionable signal for vendors in that product category.